Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group (Q33396737)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group |
scientific article |
Statements
1 reference
Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group (English)
1 reference
Clemens-Martin Wendtner
1 reference
Valentin Goede
1 reference
Hartmut Döhner
1 reference
Michael Hallek
1 reference
Jasmin Bahlo
1 reference
Kirsten Fischer
1 reference
Paula Cramer
1 reference
Raymonde Busch
1 reference
Carmen D Schweighofer
1 reference
Sebastian Böttcher
1 reference
Peter Staib
1 reference
Michael Kiehl
1 reference
Michael J Eckart
1 reference
Gabriele Kranz
1 reference
Thomas Elter
1 reference
Andreas Bühler
1 reference
Dirk Winkler
1 reference
Michael Kneba
1 reference
Barbara F Eichhorst
1 reference
15 August 2011
1 reference
1 reference
Identifiers
1 reference